![]() ![]() Healthcare costs also increased, with mean pharmacy costs more than tripling following development of nmCPRC ($2074 vs $6839). Mean inpatient stays increased from 0.2 to 0.5 per-patient-per-year (PPPY) following onset of nmCRPC and from 0.6 to 2.8 PPPY following onset of mCRPC. In addition, the study found that health resource utilization increased following onset of nmCRPC and progression to metastatic castration-resistant prostate cancer (mCRPC).
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |